Sarcopenic Obesity and Endocrinal Adaptation with Age
Open accessThe DOI matches its Crossref record; 182 of the 183 references it cites were found in a registry or an index.
Abstract
In normal aging, changes in the body composition occur that result in a shift toward decreased muscle mass and increased fat mass. The loss of muscle mass that occurs with aging is termed sarcopenia and is an important cause of frailty, disability, and loss of independence in older adults. Age-related changes in the body composition as well as the increased prevalence of obesity determine a combination of excess weight and reduced muscle mass or strength, recently defined as sarcopenic obesity. Weight gain increases total/abdominal fat, which, in turn, elicits inflammation and fatty infiltration in muscle. Sarcopenic obesity appears to be linked with the upregulation of TNF- α , interleukin (IL)-6, leptin, and myostatin and the downregulation of adiponectin and IL-15. Multiple combined exercise and mild caloric restriction markedly attenuate the symptoms of sarcopenic obesity. Intriguingly, the inhibition of myostatin induced by gene manipulation or neutralizing antibody ameliorates sarcopenic obesity via increased skeletal muscle mass and improved glucose homeostasis. In this review, we describe the possible influence of endocrinal changes with age on sarcopenic obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, obesity in the elderly can favor joint dysfunction, chronic pain, disabilities relating to activities of daily living, and frailty, damaging functional status more than obesity or sarcopenia alone [31, 67–70].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the age of 70 years, fat-free mass and fat mass tend to decrease in parallel.21”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Aging comes with is a decrease in anabolic hormones such as testosterone and GH.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“The pathophysiology of this condition involves a complex interplay between muscle, adipose tissue, hormonal changes, inflammation, oxidative stress and lifestyle factors, among others.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [48]
In the citing paper
“IR is a feature of aging and obesity in humans and rodents.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [31]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600
RetractedPharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
HASKELL, W. L., LEE, I.-M., PATE, R. R., POWELL, K. E., BLAIR, S. N., FRANKLIN, B. A., MACERA, C. A., HEATH, G. W., THOMPSON, P. D., & BAUMAN, A. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180616b27 · Cited by 4,616
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin stimulates fatty acid oxidation and glucose uptake in skeletalmuscle [126] and adipose tissue [127], effects which are dependent on AMP-activated protein kinase (AMPK) signaling.”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013 · cited 2×
“[105] A.”
BackgroundBody-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Research works printed but not linked: 1
- Sakuma K Yamaguchi A Perloft JW Wong AH Sarcopenia: molecular mechanisms and current therapeutic strategy Cell Aging 2011 New York, NY, USA Nova Science 93 152
Cited by
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“Decreased levels of anabolic hormones, such as growth hormone, insulin-like growth factor 1 (IGF1) and testosterone, contribute to muscle loss and hindered protein synthesis 48 .”
InfluentialNew obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso‐Mateos, J. L., Miret, M., Chatterji, S., Tobiasz‐Adamczyk, B., Koskinen, S., Leonardi, M., & Haro, J. M. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12076 · Cited by 288
“The concept of sarcopenic obesity is complex with various underlying elements such as endocrine, inflammatory, and lifestyle factors.(3,39) The presence of obesity concomitant with low muscle mass tissue or strength is highly related with metabolism-related diseases, such as metabolic syndrome and functional disabilit…”
BackgroundObesity subtypes, related biomarkers & heterogeneity
Mayoral, L. P.-C., Andrade, G. M., Mayoral, E. P.-C., Huerta, T. H., Canseco, S. P., Rodal Canales, F. J., Cabrera-Fuentes, H. A., Cruz, M. M., Pérez Santiago, A. D., Alpuche, J. J., et al. (2020) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1768_17 · Cited by 277
Frailty and sarcopenia - newly emerging and high impact complications of diabetes
Sinclair, A. J., Abdelhafiz, A. H., & Rodríguez-Mañas, L. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.003 · Cited by 276
Obesity, insulin resistance and comorbidities? Mechanisms of association
Castro, A. V. B., Kolka, C. M., Kim, S. P., & Bergman, R. N. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003223 · Cited by 254
“Sarcopenia associated with aging and lack of exercise is one factor leading to decreased FFA oxidative capacity and fat accumulation (18,50).”
BackgroundBilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. (2022) · Cells · doi:10.3390/cells11010160 · Cited by 251
“Some studies have suggested that low IL-15 levels may play a role in sarcopenia’s pathogenesis [427,428].”
BackgroundThe implications of sarcopenia and sarcopenic obesity on cardiometabolic disease
Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225
“Increased circulating levels of tumor necrosis factor-alpha (TNF-a), interleukin-6 (IL-6), interleukin-1 (IL-1), and C-reactive protein (CRP) have been reported in subjects with SO.”
BackgroundInfluentialAngulo, J., El Assar, M., & Rodríguez-Mañas, L. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.06.001 · Cited by 182
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00359-9 · Cited by 176
Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
“The inhibition of MSTN induced by gene manipulation or neutralizing antibodies improves sarcopenic obesity by increasing skeletal muscle mass and improving glucose homeostasis [1].”
BackgroundInfluentialThe Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression
Chen, Z., Li, W., Ho, M. M., & Chau, P. H. (2021) · Nutrients · doi:10.3390/nu13051441 · Cited by 155
“Advancing age is marked by a series of physiological changes in body composition, including the decrease in skeletal muscle mass and increase in fat mass [3,4].”
BackgroundSarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151
“In contrast to adiponectin, leptin, another major adipokine, is positively correlated with fat mass (Sakuma and Yamaguchi 2013).”
BackgroundInfluentialInterplay of skeletal muscle and adipose tissue: sarcopenic obesity
Park, M., & Choi, K. M. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155577 · Cited by 150
Exercise therapy for people with sarcopenic obesity: myokines and adipokines as effective actors
Alizadeh Pahlavani, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.811751 · Cited by 145
“IL-10 in the serum is positively associated with obesity in humans (25).”
BackgroundInfluentialObesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
Preda, A., Carbone, F., Tirandi, A., Montecucco, F., & Liberale, L. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09813-5 · Cited by 143
“Preclinical and clinical studies suggest the existence of a biological connection between IR, obesity and sarcopenia, mediated by the impaired function of the growth differentiation factor myostatin [82].”
BackgroundNutritional influences on age-related skeletal muscle loss
Welch, A. A. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113003698 · Cited by 133
“However, the evidence for an increase in myostatin levels in blood with ageing is equivocal((113,114)).”
BackgroundCarias, S., Castellanos, A. L., Vilchez, V., Nair, R., Dela Cruz, A. C., Watkins, J., Barrett, T., Trushar, P., Esser, K., & Gedaly, R. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13166 · Cited by 130
Sarcopenic Obesity: An Emerging Public Health Problem
Ji, T., Li, Y., & Ma, L. (2022) · Aging and disease · doi:10.14336/ad.2021.1006 · Cited by 124
“In SO, adipocytes accumulate in muscle tissue and other organs (heart, liver and pancreas and so on) and secrete proinflammatory cytokines (TNF-α, IL-6, IL-1 and leptin), thus leading to the infiltration of inflammatory cells and inducing insulin resistance and lipotoxicity, which directly affects skeletal muscle and…”
BackgroundTyrovolas, S., Panagiotakos, D., Georgousopoulou, E., Chrysohoou, C., Tousoulis, D., Haro, J. M., & Pitsavos, C. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2019-212268 · Cited by 123
Factors mediating spaceflight-induced skeletal muscle atrophy
Lee, P. H. U., Chung, M., Ren, Z., Mair, D. B., & Kim, D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2021 · Cited by 123
Applications of Medium-Chain Triglycerides in Foods
Watanabe, S., & Tsujino, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.802805 · Cited by 116
“These include impaired neurological effects, chronic inflammatory conditions, oxidative stress, and decreased levels of sex hormones (60) and growth hormone (63).”
BackgroundMyostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Wagenaar, C. A., Dekker, L. H., & Navis, G. J. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.005 · Cited by 105
Berezin, A. Е., Berezin, A. A., & Lichtenauer, M. (2021) · Disease Markers · doi:10.1155/2021/6644631 · Cited by 101
“Low circulating levels of IL-15 were found in younger and older people with sarcopenia without known HF [161, 162].”
BackgroundImpact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
“This may be perpetuated by reactive-oxygen-species (ROS) production in the elderly [80], which activate the NF-κB signaling pathway [81]—an activator of IL-6 and TNF-α release [76].”
BackgroundSearching for the link between inflammaging and sarcopenia
Wang, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101611 · Cited by 98
Overfat and Underfat: New Terms and Definitions Long Overdue
Maffetone, P. B., Rivera-Dominguez, I., & Laursen, P. B. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00279 · Cited by 96
“Changes in body composition, resulting from a shift across the overfat conditions toward one of decreased muscle mass in combination with maintained or increased FM (89), may increase rates of sarcopenic obesity, described as the combination of increased body fat in conjunction with reduced muscle mass (66, 72).”
BackgroundYanai, H. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2361w · Cited by 93
“Sarcopenic obesity is associated with the upregulation of inflammatory cytokines [5], which further deteriorates sarcopenia [6].”
BackgroundSarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people
Molino, S., Dossena, M., Buonocore, D., & Verri, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0631-8 · Cited by 91
“Elevated pancreatic fat with declining cell function also plays a role (47).”
The role of muscle mass and body fat on disability among older adults: A cross-national analysis
Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso‐Mateos, J. L., Miret, M., Chatterji, S., Tobiasz‐Adamczyk, B., Koskinen, S. V. P., Leonardi, M., & Haro, J. M. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.002 · Cited by 85
Sampaio, R. A. C., Sewo Sampaio, P. Y., Yamada, M., Yukutake, T., Uchida, M. C., Tsuboyama, T., & Arai, H. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12206 · Cited by 84
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundInfluentialSarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome
Mirzai, S., Carbone, S., Batsis, J. A., Kritchevsky, S. B., Kitzman, D. W., & Shapiro, M. D. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00571-2 · Cited by 77
“Sarcopenic obesity shares common etiological mechanisms with CVD, including the imbalance between pro-inflammatory adipokines and anti-inflammatory myokines, oxidative stress, and mitochondrial dysfunction [7, 22].”
BackgroundImpact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., & Yoneda, M. (2023) · Nutrients · doi:10.3390/nu15040891 · Cited by 69
“Hyperleptinemia is positively correlated with fat mass (FM) [63] and may promote insulin resistance, liver inflammation, and fibrosis [64].”
BackgroundProtein Energy Wasting and Sarcopenia in Dialysis Patients
Hara, H., Nakamura, Y., Hatano, M., Iwashita, T., Shimizu, T., Ogawa, T., Kanozawa, K., & Hasegawa, H. (2018) · Contributions to nephrology · doi:10.1159/000485729 · Cited by 68
Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 68
“Hyperleptinemia is positively correlated with fat mass (FM) (72) and may facilitate IR, liver inflammation and fibrosis (73).”
BackgroundInflammatory and Oxidative Stress Markers in Skeletal Muscle of Obese Subjects
Catalán, V., Frühbeck, G., & Gómez‐Ambrosi, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00008-8 · Cited by 66
Oh, C., Jeon, B. H., Reid Storm, S. N., Jho, S., & No, J.-K. (2017) · Nutrition · doi:10.1016/j.nut.2016.06.004 · Cited by 60
Lim, J. P., Chong, M. S., Tay, L., Yang, Y. X., Leung, B. P., Yeo, A., Yew, S., Tan, C. H., & Lim, W. S. (2019) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2018.11.006 · Cited by 60
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041917 · Cited by 56
“The obesity-induced suppression of adiponectin leads to persistent chronic inflammation in muscle tissue [41].”
BackgroundInfluentialMinniti, G., Pescinini-Salzedas, L. M., Minniti, G. A. D. S., Laurindo, L. F., Barbalho, S. M., Sinatora, R. V., Sloan, L. A., Haber, R. S. D. A., Araújo, A. C., Quesada, K. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113452 · Cited by 56
Cabrera, D., Ruiz, A., Cabello‐Verrugio, C., Brandan, E., Estrada, L. D., Pizarro, M., Solís, N., Torres, J., Francisco Barrera, M., & Arrese, M. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4285-0 · Cited by 56
Sleep disturbance, obesity, physical fitness and quality of life in older women: EXERNET study group
Moreno-Vecino, B., Arija-Blázquez, A., Pedrero‐Chamizo, R., Gómez‐Cabello, A., Alegre, L. M., Pérez-López, F. R., González‐Gross, M., Casajús, J. A., Ara, I., & on behalf of the EXERNET Group (2017) · Climacteric · doi:10.1080/13697137.2016.1264934 · Cited by 56
Daskalopoulou, C., Wu, Y., Pan, W., Giné-Vázquez, I., Prince, M. J., Prina, M. A., & Tyrovolas, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-76575-4 · Cited by 56
da Silva, T. L., Nogueira, V. D. S. C. S., & Mulder, A. D. R. P. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.031 · Cited by 57
Ylitalo, K. R., & Karvonen-Gutierrez, C. A. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.044 · Cited by 53
Obesity in the Context of Aging: Quality of Life Considerations
Corica, F., Bianchi, G. P., Corsonello, A., Mazzella, N., Lattanzio, F., & Marchesini, G. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0237-8 · Cited by 51
Factors Associated With the Development of Sarcopenia in Kidney Transplant Recipients
Yanishi, M., Kimura, Y., Tsukaguchi, H., Koito, Y., Taniguchi, H., Mishima, T., Fukushima, Y., Sugi, M., Kinoshita, H., & Matsuda, T. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.12.015 · Cited by 52
Chiu, H., Chiu, C., Yang, R., Chan, D., Liu, S., & Chiang, C. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12289 · Cited by 51
“testosterone, vitamin D, and parathyroid hormone).(49,50)”
Maffetone, P. B., Rivera-Dominguez, I., & Laursen, P. B. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00190 · Cited by 50
“Muscle atrophy can coexist with an accumulation of fat within existing muscle, and the combination of higher body fat and sarcopenia has been termed sarcopenic obesity (87, 88), which we refer to henceforth in this paper as sarcopenic overfat.”
BackgroundKob, R., Fellner, C., Bertsch, T., Wittmann, A., Mishura, D., Sieber, C. C., Fischer, B. E., Stroszczynski, C., & Bollheimer, C. L. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12019 · Cited by 48
“The decline in muscle is accompanied by an increase in fat mass, particularly visceral fat.(7) Moreover, obesity has been shown to be associated with a functional decline in older adults.”
BackgroundAlalwan, T. A. (2020) · Geriatrics · doi:10.3390/geriatrics5010008 · Cited by 47
“Testosterone deficiency further predisposes men to visceral obesity and metabolic syndrome [48].”
BackgroundCardiometabolic disease in the older person: prediction and prevention for the generalist physician
Sinclair, A. J., & Abdelhafiz, A. H. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000193 · Cited by 47
Matsushita, T., Nishioka, S., Taguchi, S., Yamanouchi, A., Nakashima, R., & Wakabayashi, H. (2020) · Healthcare · doi:10.3390/healthcare8030255 · Cited by 44
Role of Metabolic Stress and Exercise in Regulating Fibro/Adipogenic Progenitors
Collao, N., Farup, J., & Lisio, M. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00009 · Cited by 42
“Eventually, these changes lead to a detrimental effect on contractile function and/or metabolic properties of skeletal muscle having an important impact on human health and contribute to insulin resistance (Sakuma and Yamaguchi, 2013).”
BackgroundHorii, N., Sawda, Y., Kumamoto, T., Tsuchiya, N., Murakami, T., Yabushita, Y., Honma, Y., Matsuyama, R., Morioka, D., Akiyama, H., et al. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-01836-5 · Cited by 40
Kim, S. H., Kang, H. W., Jeong, J. B., Lee, D. S., Ahn, D., Kim, J. W., Kim, B. G., Lee, K. L., Oh, S., Yoon, S. H., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256083 · Cited by 41
“The production of TNF-alpha, IL-6, and CRP from adipose tissue influences insulin resistance [69].”
BackgroundMáximo, R. D. O., de Oliveira, D. C., Ramírez, P. C., Luiz, M. M., de Souza, A. F., Delinocente, M. L. B., Steptoe, A., de Oliveira, C. M., & Alexandre, T. D. S. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac023 · Cited by 40
“This process is mediated by low-grade inflammation, which promotes insulin resistance and muscle catabolism and affects the repair of motor neurons (18, 19).”
Coelho‐Júnior, H. J., Sampaio, R. A. C., Gonçalves, I. D. O., Aguiar, S. D. S., Palmeira, R., de Oliveira, J. F., Asano, R. Y., Sampaio, P. Y. S., & Uchida, M. C. (2016) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0160110906 · Cited by 39
“8,9,11 Thus, obesity is a public health concern, and continuous monitoring and early detection can prevent the onset of its adverse outcomes.”
BackgroundCarvalho, L. P., Basso-Vanelli, R. P., Thommazo‐Luporini, L. D., Mendes, R. G., Oliveira‐Junior, M. C., Vieira, R. P., Bonjorno-Júnior, J. C., de Oliveira, C. R., Luporini, R. L., & Borghi‐Silva, A. (2017) · Cytokine · doi:10.1016/j.cyto.2017.12.008 · Cited by 36
“Thus, MSTN inhibition should be further explored as a strategy to counteract the development of diabetes and metabolic syndrome in obese people early in life to avoid the development of sarcopenic obesity at an older age, which has been previously linked to the upregulation of TNF-α, leptin and MSTN and the downregula…”
BackgroundMyokine, a key cytokine for physical exercise to alleviate sarcopenic obesity
Zhang, L., Lv, J., Wang, C., Ren, Y., & Ming, Y. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07821-3 · Cited by 35
“Similarly, the pro-inflammatory myokines levels such as IL-6, TNF-α, leptin, or myostatin, which govern inflammatory responses, further reduce muscle mass and function in adipose tissue [12].”
BackgroundBody composition, dual-energy X-ray absorptiometry and obesity: the paradigm of fat (re)distribution
Ponti, F., Plazzi, A., Guglielmi, G., Marchesini, G., & Bazzocchi, A. (2019) · BJR|case reports · doi:10.1259/bjrcr.20170078 · Cited by 34
de Campos, G. C., Lourenço, R. A., & Lopes, C. D. S. (2020) · Clinics · doi:10.6061/clinics/2020/e1814 · Cited by 33
“Muscle with high levels of infiltrated fat may be more inflamed than fat-free muscle, suggesting a connection between fat mass gain, and muscles with increased triglycerides and inflammation (47,49).”
BackgroundTyrovolas, S., Haro, J. M., Mariolis, A. D., Piscopo, S., Valacchi, G., Bountziouka, V., Anastasiou, F., Zeimbekis, A., Tyrovola, D., Foscolou, A., et al. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.04.017 · Cited by 33
Treating sarcopenic obesity in the era of incretin therapies: perspectives and challenges
Chen, A. S., & Batsis, J. A. (2025) · Diabetes · doi:10.2337/dbi25-0004 · Cited by 32
Han, Q., Kim, S. I., Yoon, S. H., Kim, T. M., Kang, H., Kim, H. J., Cho, J. Y., & Kim, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.741071 · Cited by 30
“excessive intake and lack of physical exercise (50, 51).”
BackgroundMa, X., & Chen, F. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i33.10064 · Cited by 29
Cleary, L. C., Crofford, L. J., Long, D. E., Charnigo, R. J., Clasey, J. L., Beaman, F. D., Jenkins, K. A., Fraser, N., Srinivas, A., Dhaon, N., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22557 · Cited by 29
“In addition to the effects of chronic inflammation on body composition, muscle quality, and function, patients with IIMs are also susceptible to the effects of aging and glucocorticoid use on these parameters (37).”
BackgroundJoffin, N., Jaubert, A., Durant, S., Bastin, J., Bandt, J. P. D., Cynober, L., Moinard, C., Coumoul, X., Forest, C. D., & Noirez, P. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400507 · Cited by 28
“Specifically, a rise in chronic low-grade inflammation develops when AT mass expands, because of the increase in the amount of resident macrophages and lymphocytes in AT [1, 13–15].”
BackgroundVella, C. A., Cushman, M., Hollebeke, R. B. V., & Allison, M. (2018) · Obesity · doi:10.1002/oby.22208 · Cited by 28
“Several proposed mechanisms for age-related muscle atrophy include physical inactivity, poor diet, oxidative stress, inflammation, and hormonal changes, with the mechanisms purported to be multifactorial (27).”
BackgroundFellner, C., Schick, F., Kob, R., Hechtl, C., Vorbuchner, M., Büttner, R., Hamer, O. W., Sieber, C. C., Stroszczynski, C., & Bollheimer, L. C. (2014) · Gerontology · doi:10.1159/000360289 · Cited by 28
Fighting obesity: When muscle meets fat
Yang, X., Bi, P., & Kuang, S. (2014) · Adipocyte · doi:10.4161/21623945.2014.964075 · Cited by 27
“Sarcopenic obesity is difficult to detect and treat, because subjects have a normal body weight.(122) In addition to sarcopenic obesity, aging is naturally accompanied by sarcopenia and fat deposition,(123-125) together with redistribution of body fat from appendicular to stomach and ectopic sites such as liver and mu…”
BackgroundThe Prevalence of Overfat Adults and Children in the US
Maffetone, P. B., & Laursen, P. B. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00290 · Cited by 27
“org November 2017 | Volume 5 | Article 290 accumulation of fat within existing muscle, with the combination of higher body fat and sarcopenia being termed sarcopenic obesity (64, 65).”
BackgroundPasdar, Y., Darbandi, M., Rezaeian, S., Najafi, F., Hamzeh, B., & Bagheri, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.705055 · Cited by 26
“As age increases, fat distribution changes in the body, which is associated with increased visceral fat, as well as fat depositions that happen in the liver, heart, skeletal muscle, and pancreas (17).”
BackgroundDing, Y., Deng, Q., Yang, M., Niu, H., Wang, Z., & Xia, S. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s431251 · Cited by 25
Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study
Setoyama, Y., Honda, T., Tajimi, T., Sakata, S., Oishi, E., Furuta, Y., Shibata, M., Hata, J., Kitazono, T., Nakashima, Y., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13564 · Cited by 24
[Overweight and obesity: review and update].
Quintero, F., Ariza, A. J., García, F. B., de Molano, N. C., Benavides, M. C., Muñoz, S. C., Carbajal, L. D., Olivera, M. R. D., Fernández, A., Heller, S., et al. (2016) · PubMed · Cited by 24
miRNA and leptin signaling in metabolic diseases and at extreme environments
Mondal, S., Rathor, R., Singh, S. N., & Suryakumar, G. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1248 · Cited by 23
Yamamoto, K., Motokawa, K., Yoshizaki, T., Yano, T., Hirano, H., Ohara, Y., Shirobe, M., Inagaki, H., Awata, S., Shinkai, S., et al. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1297-4 · Cited by 23
Challenges and Strategies for Diabetes Management in Community-Living Older Adults
Sinclair, A. J., & Abdelhafiz, A. H. (2020) · Diabetes Spectrum · doi:10.2337/ds20-0013 · Cited by 23
“Frailty and sarcopenia are associated with reduced muscle mass and increased visceral fat, which lead to atherosclerosis via a complex interplay of factors, including increased insulin resistance, proinflammatory cytokines, reduced physical activity, increased oxidative stress, and mitochondrial dysfunction, increasin…”
BackgroundLana, A., Struijk, E. A., Guallar‐Castillón, P., Martin-Moreno, J. M., Rodríguez‐Artalejo, F., & López‐García, E. (2016) · Age and Ageing · doi:10.1093/ageing/afw142 · Cited by 23
“In this state, the peripheral effects of leptin could prevail over its central action [18].”
BackgroundScott, D. S., & Hirani, V. (2015) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.11.009 · Cited by 21
Ghanemi, A., Melouane, A., Yoshioka, M., & St‐Amand, J. (2020) · Applied Sciences · doi:10.3390/app10249108 · Cited by 22
Learning pharmacokinetic models for in vivo glucocorticoid activation
Bunte, K., Smith, D. J., Chappell, M. J., Hassan-Smith, Z. K., Tomlinson, J., Arlt, W., & Tiňo, P. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.07.025 · Cited by 19
“In Europe, those aged > 65 years made up 17 million of the population in 1998, a number projected to rise to 25 million by 2035 ( Eurostat, 2008; Sakuma and Yamaguchi, 2013 ).”
BackgroundNutritional Considerations in Preventing Muscle Atrophy
Creţoiu, S. M., & Zugravu, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_23 · Cited by 19
Chao, Y., Chen, W., Peng, T., Wu, L., Liaw, F., & Kao, T. (2020) · Nutrition · doi:10.1016/j.nut.2020.111071 · Cited by 18
Bertuol, C., Tozetto, W. R., Streb, A. R., & Duca, G. F. D. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2021.1880646 · Cited by 18
Management of Hyperglycemia in Older Adults with Type 2 Diabetes
Gandhi, G. Y., & Mooradian, A. D. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00910-1 · Cited by 18
“Frailty and sarcopenia are associated with reduced muscle mass and increased visceral fat, leading to atherosclerosis and vascular disease [39].”
BackgroundRubio-Ruiz, M. E., Pérez-Torres, I., Díaz‐Díaz, E., Pavón, N., & Guarner‐Lans, V. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.67 · Cited by 18
Gažarová, M., Bihari, M., & Šoltís, J. (2023) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2023.0243 · Cited by 17
Obesity-Related Inflammation: Implications for Older Adults
Ellis, A. C., Crowe, K. M., & Lawrence, J. C. (2013) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2013.842199 · Cited by 18
“Circulating leptin levels rise with increasing adiposity (4, 26), thereby exacerbating inflammation.”
BackgroundInfluentialLiu-Galvin, R. E., Orlando, F. A., Saguil, A. A., Jo, A., Smith, K., Miller, A. M., Nelson, D. S., Sanders, E. C., & Mainous, A. G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1695935 · Cited by 16
“Lower lean body mass in relation to body fat is being increasingly recognized as a critical contributor to cardiometabolic risk, more so than obesity itself (35–37).”
Godziuk, K., Woodhouse, L. J., Prado, C. M. M., & Forhan, M. A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.08.005 · Cited by 16
Body Composition Outcomes of a Qigong Intervention Among Community-Dwelling Aging Adults
Chang, M.-Y., & Chen, H. (2016) · Western Journal of Nursing Research · doi:10.1177/0193945916654907 · Cited by 15
“Therefore, age-related losses in muscle mass present an extremely important public health issue (Sakuma & Yamaguchi, 2013).”
BackgroundInfluentialIsaka, M., Sugimoto, K., Akasaka, H., Yasunobe, Y., Takahashi, T., Keyu, X., Onishi, Y., Yoshida, S., Minami, T., Yamamoto, K. I., et al. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s385469 · Cited by 15
Heat shock response to exercise in pancreatic islets of obese mice
Bittencourt, A., Schroeder, H. T., Porto, R. R., Muller, C. H. D. L., Krause, M. D. S., & de Bittencourt, P. I. H. (2019) · Biochimie · doi:10.1016/j.biochi.2019.10.015 · Cited by 15
Immunogenetic Aspects of Sarcopenic Obesity
Mazurkiewicz, Ł., Czernikiewicz, K., & Grygiel‐Górniak, B. (2024) · Genes · doi:10.3390/genes15020206 · Cited by 14
“Fortunately, increased physical activity reduces the CRP level [78].”
Background
Metadata
- Authors
- Sakuma, K., & Yamaguchi, A.
- Affiliations
- Toyohashi University of Technology (JP)
- Health Sciences University of Hokkaido (JP)
- Corresponding author
- Sakuma, Kunihiro
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-12
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC3639625
- OpenAlex
- W1966294329
- Cited by
- 189
- References
- 183
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 16 · 2023: 13 · 2022: 20 · 2021: 20 · 2020: 20 · 2019: 9 · 2018: 9 · 2017: 8 · 2016: 14 · 2015: 15 · 2014: 12 · 2013: 4
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology of Japan (23500578)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenic obesity, sarcopenia, aging, body composition, muscle mass loss, frailty, obesity, inflammation, TNF-α, interleukin-6, leptin, myostatin, adiponectin, IL-15, caloric restriction, physical activity, myostatin inhibition, glucose homeostasis, skeletal muscle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.